# Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

> **NCT01675661** · PHASE3 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 302 (actual)

## Conditions studied

- Cannabis Dependence

## Interventions

- **DRUG:** N-Acetylcysteine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01675661
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 302 (ACTUAL)
- **Last updated:** 2018-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675661, "Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01675661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*